ProGenTech Grabs $21M in Venture Financing from US, China Investors | GenomeWeb
NEW YORK (GenomeWeb News) – ProGenTech said today it has raised $21 million in a round of Series C financing led by Bay City Capital of San Francisco and DT Capital of Shanghai. 
 
ProGenTech, which makes an automated nucleic acid extraction and purification system, has headquarters in Emeryville, Calif., and in Shanghai.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.